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Abstract Gene expression in Rat-1 ¢broblast cells transformed
by Tax from human T-cell leukemia virus type 1 was studied
using the reverse transcriptase polymerase chain reaction di¡er-
ential display technique. The analysis revealed eight genes that
were upregulated and one gene that was suppressed in Tax-
transformed cells. Interestingly, at least four of the upregulated
genes were interferon-stimulated genes. Promoter analysis of
the 2P,5P-oligoadenylate synthetase gene, which was activated
in both Tax-transformed Rat-1 cells and primary adult T-cell
leukemia cells, demonstrated that Tax indirectly activates its
interferon-responsive enhancer element in a nuclear factor-UB
pathway-dependent manner, indicating a close association of
interferon signaling with the transformation by Tax.
( 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Human T-cell leukemia virus type 1 (HTLV-1) is the etio-
logic agent of adult T-cell leukemia (ATL) [1,2]. The viral
protein Tax is thought to play a critical role in leukemogenesis
because of its transforming activity in various experimental
systems: the immortalization of rat embryo ¢broblasts
(REF) and human T-lymphocytes [3], ras-dependent focus
formation of REF, and anchorage-independent growth of
Rat-1 cells.
Tax transactivates its own long terminal repeat and various
cellular genes, including cytokines/chemokines (interleukin
(IL) 1K, IL-2, IL-6, IL-8, granulocyte-macrophage colony-
stimulating factor, interferon-inducible protein-10 (IP-10)),
their receptors (the a chain of the IL-2 receptor (IL-2R), IL-
15R, and CXCR4), nuclear transcriptional factors (c-fos,
c-jun, interferon regulatory factor (IRF) 4), cytoplasmic signal
mediator (lyn), apoptosis inhibitor (Bcl-XL), and G1-cyclins.
Conversely, Tax represses the transcription of some cellular
genes. Analyses of target DNA sequences revealed that Tax
activates at least three enhancer elements: those that bind to
the cyclic AMP-responsive element binding factor (CREB/
ATF), nuclear factor (NF) UB, and serum-responsive factor
(SRF). The transcriptional suppression mediated via E-box
binding protein and functional inactivation of the p53 tumor
suppressor gene product were attributed to the sequestration
of a transcriptional co-factor, CBP/p300, by Tax protein [4].
Interestingly, using a set of enhancer-speci¢c Tax mutants
[5], it was shown that distinct enhancer pathways are involved
in at least the latter two transformation phenotypes. The NF-
UB pathway is required for the anchorage-independent growth
of Rat-1 cells [6], while SRF activity is necessary in focus
formation of REF [7]. To immortalize T-cells, the inactivation
of INK4a, a tumor suppressor gene product that inhibits
CDK4/6 kinase activity, via a direct interaction with Tax in
an NF-UB-dependent manner, has been implicated [8],
although some results do not support the requirement for
the NF-UB pathway [9]. These results indicate that multiple
activities of Tax are involved in establishing the transformed
phenotype of HTLV-1-infected T-cells in ATL patients.
The Rel/NF-UB family of transcription factors regulates
gene expression via promoters or enhancers containing the
UB binding site (GGGRNNYYCC, where R is a purine, Y
is a pyrimidine, and N is any nucleotide). Rel/NF-UB proteins
coordinate the expression of genes involved in natural and
acquired immunity, and also control cell growth and apopto-
sis. In addition, altered regulation of Rel/NF-UB activity has
been linked to several pathological processes, including onco-
genesis. While Tax protein leads to persistent NF-UB activity
via the activation of IUB kinase kinases in HTLV-1-infected
T-cells [10], continuous NF-UB activation in primary ATL
cells occurs via a mechanism that is independent of Tax
[11]. Therefore, NF-UB activity seems to be involved in both
the development and maintenance of leukemogenesis caused
by HTLV-1.
Although Tax function related to NF-UB activation is re-
sponsible for Rat-1 cell transformation, its mechanism is still
totally unknown. To address this question, we searched for
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genes that are modulated by Tax in the course of transforma-
tion using the reverse transcriptase polymerase chain reaction
(RT-PCR) di¡erential display technique [12]. As a result, we
found that Tax expression in Rat-1 cells leads to transcrip-
tional activation of a series of interferon-stimulated genes
(ISGs) and promoter analysis of the 2P,5P-oligoadenylate syn-
thetase (2,5-OAS) gene, which was activated in both Tax-
transformed Rat-1 cells and primary ATL cells, revealed
that Tax activates its interferon-responsive enhancer element
in a manner dependent on the NF-UB pathway. These results
suggest a close association of interferon signaling with the
transformed phenotype.
2. Materials and methods
2.1. Cell culture and Tax expression
Rat-1 and HeLa cells were grown in Dulbecco’s modi¢ed Eagle’s
medium supplemented with 5% fetal calf serum. To obtain Tax-trans-
formed Rat-1 cells, 105 cells were infected with 102^103 cfu of MLV-
based recombinant retrovirus expressing Tax (RTaxbsr [13]) and its
mutants, and selected for 10 days in 10 ml of culture medium con-
taining 10 Wg/ml blasticidin S (Kakenseiyaku, Tokyo, Japan). Re-
combinant retroviruses were produced by transfecting retroviral vec-
tor DNA, pRTaxbsr [13], or its derivatives, into BOSC23 packaging
cells using LipofectAmine (Gibco BRL, Grand Island, NY, USA).
Human interferon-K was obtained from Sumitomo Pharmaceutical
(Takarazuka, Japan).
2.2. RT-PCR di¡erential display analysis and cDNA isolation
Di¡erential display of total RNA was performed as previously de-
scribed [12]. Brie£y, 5 Wg of total RNA prepared from a pool of about
100 cell clones transformed with wild-type Tax or its mutant forms
were reverse-transcribed using SuperScript-II (Gibco BRL) with one
of four degenerate anchored oligo-dT primers (T12VG, T12VA,
T12VT, and T12VC, where V may be G, A, or C), containing 12 T
nucleotides. The single-stranded cDNA was then used in PCR with
one of these four 3P primers and one of 20 possible arbitrary random
decamers (OPA-1 to OPA-20) as 5P primers. The PCR products were
resolved on denaturing 6% polyacrylamide gels to obtain a pro¢le of
the RNA population. The band pattern obtained with Tax-trans-
formed Rat-1 was compared with that obtained with Rat-1 cells trans-
formed with empty retrovector and the PCR products representing
mRNA whose expression was altered by Tax transformation were
excised from the acrylamide gel, re-ampli¢ed with the same primers,
and cloned into pGEM-T Easy vector (Promega, Madison, WI,
USA).
To isolate the full-length cDNA, VZAP cDNA libraries prepared
with poly(A)þ mRNA from Rat-1 or Tax-transduced Rat-1 cells were
screened using 32P-labeled cDNA fragments obtained in the di¡er-
ential display analysis. The nucleotide sequences of these cDNAs
were determined and analyzed by searching for homologous sequences
in GenBank using the search program BLAST.
2.3. Northern and RT-PCR analysis
Total RNA (10 Wg) prepared from Rat-1 cells transformed with Tax
and its mutants was separated in a 1% agarose gel containing 10%
formalin in 1UMOPS, transferred to a Hybond-Nþ membrane
(Amersham Pharmacia Biotech, Buckinghamshire, UK), and then
probed with a 32P-labeled cDNA fragment.
For RT-PCR, cDNA was synthesized from 5 Wg of total RNA
using SuperScript-II reverse transcriptase and an oligo-dT1218 primer
(Amersham). The same amounts of cDNA were subjected to 30 cycles
of PCR in 20 Wl of reaction bu¡er containing 10 pmol of each primer.
The individual cycles consisted of 20 s at 98‡C and 2 min at 68‡C; the
sequences of oligonucleotide primers were as follows: for rat 2,5-
OAS-1, 5P-GGAGATACATTCGGAGATGAGGAT-3P and 5P-CCT-
GGTCATGCATCCTGCTGTGAA-3P ; for rat 2,5-OAS-2, 5P-AGAT-
TAACTAAGTTCAACACAGCC-3P and 5P-ACTTTGGGCTATAC-
AGAATGCTTC-3P ; for rat IP-10, 5P-CTGTCGTTCTCTGCCTC-G-
TGCTGC-3P and 5P-CCGTCTCTCTGCTGTCCATCGGTC-3P ; for
human 2,5-OAS, 5P-CTCATCCGCCTAGTCAAGCACTGG-3P and
5P-AGCTATATGCTCAAGCTTCATGG-3P ; for human IP-10, 5P-
TGATTTGCTGCCTTATCTTTCTGA-3P and 5P-CAGCCTCTGTG-
TGGTCCATCCTTG-3P ; for rat and human L-actin, 5P-GTGTTGA-
AGGTCTCAAACATGATCTGGGTC-3P and 5P-CAAGATCATTG-
CTCCTCCTGAGCGCAAGTA-3P.
2.4. Luciferase assay
Luciferase reporter plasmids were constructed by inserting human
2,5-OAS promoter fragments, which were isolated by PCR of HeLa
cell genomic DNA, into the multi-cloning site of pGL3-basic plasmid.
Expression plasmids for Tax and NF-UB, pCGTax and pCGp65 have
been described previously [14]. The human IRF-3 coding region was
ampli¢ed by PCR, sequence-veri¢ed and subcloned into an empty
vector resulting in pCG-IRF-3. The expression plasmid for the dom-
inant negative form of NF-UB [15], pCGDNUB, was constructed by
inserting a 1.1-kb PstI-XbaI fragment of NF-UB p105 precursor
cDNA into the pCG vector. The reporter plasmids (50 ng) were trans-
fected to HeLa cells grown in 24-well multi-well dishes with 50 ng of a
control vector, pRL-RSV (Promega), and 20 ng each of e¡ector plas-
mids by using LipofectAmine (Gibco BRL). The cell lysates were
prepared after 24 h and the luciferase assay was performed according
to the manufacturer’s protocol for the Dual-Luciferase Reporter As-
say System (Promega).
3. Results
3.1. Genes di¡erentially expressed in Tax-transformed
Rat-1 cells
About 1000 transcripts were analyzed by RT-PCR di¡er-
ential display using combinations of 20 di¡erent arbitrary
primers and four anchor primers. Eighty-seven cDNA frag-
ments that were di¡erentially expressed between mock- and
Tax-transformed Rat-1 cells were isolated from gels and sub-
cloned into vector plasmid. Using these fragments as probes,
the enhanced or suppressed expression of di¡erentially ex-
pressed genes was analyzed by Northern blot analysis. Since
most cDNA bands in the di¡erential display consisted of
multiple fragments encoding 3P-non-coding regions, which ex-
hibited relatively low a⁄nity and speci¢city in the hybridiza-
tion, for only nine cDNA fragments could the di¡erential
expression be successfully con¢rmed. As shown in Fig. 1A,
eight genes were concluded to be upregulated in Tax-trans-
formed Rat-1 cells and the transcription of one gene was
decreased in these cells.
Longer or full-length cDNAs were further screened by the
same probes in cDNA libraries of Rat-1 or Tax-transduced
Rat-1 cells. The nucleotide sequences of these cDNAs were
determined and the identity of each clone was analyzed in a
BLAST homology search. The BLAST search revealed that
these genes included rat orthologues of a subtype of 2,5-OAS
(we named and deposited it as rat 2,5-OAS-2, but have re-
cently found it most homologous to murine OAS-1b [16]), IP-
10 [17], CyCAP/90K/MAC-2 binding protein [18], schlafen-4
[19], metallothionein-2, intra-cisternal A particle [20], and cal-
pain-6 [21].
3.2. Activation of genes in Tax-transformed cells involves the
NF-UB pathway
The expression of these genes was also analyzed in Rat-1
cells that were transduced with various Tax mutants. Mutant
v3, which lacks three amino acids at the amino-terminus end,
activates the NF-UB pathway, but fails to activate the CREB/
ATF and SRF pathways [22]. Conversely, mutant M22, which
has a Thr-Leu to Ala-Ser substitution at the 130th amino
acid, cannot activate the NF-UB pathway, but retains the
ability to activate the CREB/ATF and SRF pathways [5].
Northern analysis of transcripts in cells transformed with
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Tax mutants revealed that six out of the eight upregulated
genes appeared to be activated in the v3 transformant, but
not in the M22 transformant, although the magnitude of en-
hancement in the v3 mutant was minimal for most of these
genes (Fig. 1A). The activation of 2,5-OAS-2 and IP-10 genes
in the v3 transformant was con¢rmed by RT-PCR as shown
in Fig. 1B. The results suggest that these genes are activated
by Tax at least partly in an NF-UB-dependent manner. In the
full activation of these genes, the CREB/ATF and SRF path-
ways or some unknown pathway could be synergistically in-
volved with the NF-UB pathway.
Two of the upregulated genes did not match any known
genes and appeared to be activated little by v3 and M22
mutants. These genes were not analyzed further because of
lack of the NF-UB dependence, which is associated with
Rat-1 transformation. Of interest, no gene was upregulated
by M22, indicating that few genes are activated solely via
the CREB/ATF and SRF pathways in Tax-transformed cells.
By contrast, suppressed expression of the calpain-6 gene was
observed in cells transformed with wild-type Tax and partially
in those with M22 mutants (Fig. 1A).
3.3. Interferon-inducible genes were activated in
Tax-transformed Rat-1 cells
Of the six upregulated genes, four were previously reported
to be interferon-stimulated genes (ISGs). IP-10 is a CXC che-
mokine that has been cloned as a protein induced by interfe-
ron-Q [17]. CyCAP (cyclophilin C-associated protein [18], also
known as 90K/MAC-2 binding protein, a glycoprotein be-
longing to the scavenger receptor family) has been identi¢ed
as an intracellular ligand of cyclophilin C and is induced by
Fig. 1. Expression of modulated genes in Tax-transformed Rat-1
cells. A: Total RNAs (10 Wg/lane) from Rat-1 cells transformed
with Tax and its mutant forms, M22 and v3, on a transfer mem-
brane were hybridized with a 32P-labeled probe for the respective
cDNAs. The ¢rst lane contained RNA from Rat-1 cells transduced
with an empty retrovector. Approximate lengths of hybridized
mRNAs are presented. B: Activation of mRNA expressions from
rat 2,5-OAS-1, 2,5-OAS-2 and IP-10 genes in Tax-transformed
Rat-1 cells was demonstrated by RT-PCR. Expression of L-actin
mRNA is presented as a control in both A and B.
Fig. 2. Transcriptional activation of 2,5-OAS promoter by IFN-K
and Tax. A: Structures of human 2,5-OAS reporter plasmids and
nucleotide sequences of ISRE-B and its mutant. B: Both interferon-
K treatment (100 U/ml, white bar) and Tax expression (hatched bar)
stimulated ISRE of 2,5-OAS promoter in HeLa cells. Luciferase ac-
tivities were normalized based on the Renilla luciferase activity from
pRSV-RL and are shown as fold activation to that of control trans-
fection with empty expression vector. Mean values and standard er-
rors for four independent assays are presented.
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the action of interferon [23]. Genes for metallothionein-1 and
-2 are also interferon-responsive [24].
Rat 2,5-OAS-2 is a gene related to 2,5-OAS-1, which is one
of the best-characterized ISGs. Therefore, we examined the
expression of rat 2,5-OAS-1 in Tax-transformed Rat-1 cells
by RT-PCR and demonstrated that activation of its gene is
associated with Tax expression in an NF-UB-dependent man-
ner (Fig. 1B).
3.4. Tax-activated interferon-responsive element in Rat-1 cells
We then asked whether interferon stimulation and Tax ac-
tivation share a pathway in the transactivation of interferon-
inducible genes. To answer this question, a luciferase reporter
plasmid was constructed using the interferon-responsive pro-
moter fragment from the human 2,5-OAS gene, in which the
interferon response has been extensively studied [25] (Fig. 2A).
When HeLa cells were transfected with the reporter plasmid
containing a promoter fragment (3159 to +82) and treated
with human interferon-K, luciferase expression was enhanced
about 10-fold. By contrast, on deleting the nucleotide se-
quence harboring two interferon response elements (ISRE-A
and ISRE-B, Fig. 2A), the interferon response was lost
(385Luc, Fig. 2B). When the Tax expression plasmid was
co-transfected, the reporter plasmids with two or one of the
2,5-OAS enhancer elements, 3159Luc and 3125Luc, but not
the enhancer-less reporter, were activated (6.2- and 2.9-fold,
respectively) by Tax to a similar extent as with interferon
stimulus (10.7- and 3.0-fold, respectively). In addition, the
reporter plasmid containing a hexamer of the ISRE-B frag-
ment on the enhancer-less promoter was activated by Tax co-
transfection as well as by interferon stimulation (B6Luc, Fig.
2B). Introduction of a mutation in the ISRE-B sequence abol-
ished both forms of activation (muB6Luc, Fig. 2B), con¢rm-
ing the involvement of ISRE in Tax activation.
3.5. NF-UB-dependent activation of ISRE
All of the ISGs upregulated in Tax-transformed cells
seemed to be activated in an NF-UB-dependent manner.
Therefore, we examined whether NF-UB transcription factors
were actually involved in the transactivation of ISGs via the
ISRE sequence.
As shown in Fig. 3, overexpression of the p65 subunit of
the NF-UB molecule resulted in the activation of ISRE. Fur-
thermore, a dominant negative form of the NF-UB molecule
[15], which inhibits the binding of Rel/NF-UB proteins to
DNA, was co-transfected, and both the Tax- and NF-UB-de-
pendent stimulations of the ISRE reporter were diminished,
whereas the activation of ISRE by the over-expression of
IRF-3, which plays a prominent role in the interferon induc-
tion via ISRE, was not a¡ected. Since there is no evidence
that NF-UB molecules directly associate with the ISRE se-
quence, it is more likely that some other factor(s), which
may be induced by the function of NF-UB, is involved in
the modulation caused by the ISRE sequence.
3.6. 2,5-OAS activation in peripheral blood lymphocytes from
ATL patients
Although the in vivo expression of HTLV-1 including the
Tax gene in primary ATL cells was suppressed, continuous
NF-UB activation was observed via a mechanism that is inde-
pendent of Tax, suggesting that NF-UB activity is involved in
both the development and maintenance of leukemogenesis
caused by HTLV-1. Therefore, it was of interest whether the
induction of ISGs was common to primary ATL cells. To
assess this possibility, expressions of 2,5-OAS and IP-10
were analyzed using an RT-PCR procedure using total
RNA prepared from peripheral blood mononuclear cells
(PBMCs) from ATL patients.
As shown in Fig. 4, transcription from the human 2,5-OAS
gene was upregulated in all cases of ATL leukemic cells tested,
whereas normal PBMC exhibited little expression. Therefore,
2,5-OAS is also activated in primary ATL cells, indicating the
ISRE activation in ATL cells. Combined with the result of
ISRE activation by NF-UB signaling in the 2,5-OAS pro-
moter, a close association of interferon signaling with the
transforming phenotype of ATL cells is strongly suggested.
However, although three out of seven ATL cases exhibited
the upregulation of the IP-10 gene, the remainder of the ATL
cells expressed a similar or even decreased level of transcrip-
tion when compared with that in normal PBMC. These results
indicate that NF-UB activity may not necessarily result in the
induction of all ISGs, which is probably dependent on the
con¢guration of enhancer elements and the cell type.
Fig. 3. Activation of ISRE by Tax and NF-UB. B6Luc reporter
plasmid (50 ng) was transfected to HeLa cells with expression plas-
mids (20 ng) for Tax, p65, and IRF-3 in the presence (+) or ab-
sence (3) of the dominant negative NF-UB expressor (20 ng). Lucif-
erase activities were measured and presented as in Fig. 2.
2-5OAS
β-actin
1     2     3     4     5     6     7     8 
8   
IP-10
Fig. 4. Expressions of human 2,5-OAS and IP-10 genes in ATL leu-
kemic cells. 0.1 Wg of total RNA from PBMCs of ATL patients
(lanes 1^7) and a healthy donor (lane 8) was reverse-transcribed and
PCR-ampli¢ed with primer pairs for human 2,5-OAS (upper panel),
IP-10 (middle panel) and L-actin (lower panel).
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4. Discussion
Using an RT-PCR di¡erential display technique, we iden-
ti¢ed six genes whose expression was speci¢cally modulated in
Tax-transformed Rat-1 cells, and at least four of them were
found to be ISGs. Promoter analysis of one of the activated
genes, 2,5-OAS, revealed that Tax activated its ISRE in an
NF-UB pathway-dependent manner. These results strongly
suggest that some other factor(s), which may be induced by
the function of NF-UB, is involved in the modulation caused
by the ISRE sequence in Tax-transformed Rat-1 cells.
There is increasing evidence of a close link between inter-
feron signaling and NF-UB activity. Activation of cells by
either double-stranded RNA or bacterial lipopolysaccharide
(LPS) via Toll-like receptor (TLR)-3 and TLR-4, respectively,
which leads to the induction of type I interferons and various
ISGs, involves activation of both IRFs and NF-UB [26]. Using
LPS-stimulated human umbilical vein endothelial cells, Liu et
al. found evidence of the direct involvement of NF-UB in the
induction of IRF-1 [27]. The induction and activation of IRF-
7 by Epstein^Barr virus (EBV) latent membrane protein 1 is
also attributed to the NF-UB signaling pathway [28], and IRF-
7 has been suggested to have a role in latent EBV infection.
Therefore, the induction of ISGs by NF-UB in HTLV-1-in-
fected cells might help to sustain the lower expression of viral
genes, allowing them to escape the host immune system [29].
In terms of cellular transformation, IRF-4, which is abun-
dant in HTLV-1-infected T-cells [30,31], is of the most inter-
est, because v-Rel transformation of chick embryo ¢broblasts
has recently been demonstrated to involve the induction of
IRF-4 as well as the expression of several ISGs [32]. Since
the suppression of IRF-4 expression by antisense RNA re-
versed the transformed phenotype of the ¢broblast, the au-
thors suggested that IRF-4 facilitates transformation by de-
creasing the anti-proliferative e¡ects of ISGs. Therefore, IRF-
4 may also be involved in the NF-UB-dependent transforma-
tion of Rat-1 cells by Tax. In fact, our preliminary experiment
demonstrated that over-expression of IRF-4 did activate the
reporter plasmid with the ISRE sequence of the 2,5-OAS gene
(data not shown). Furthermore, a role for IRF-4 in the tran-
scriptional regulation of IL-15 receptor K by HTLV-1 Tax has
also been demonstrated recently [33]. Combined with our re-
sult that expression of the 2,5-OAS gene was observed in
primary ATL cells, in which NF-UB activity is consistently
augmented, it would be possible that IRF-4 is involved in
the transforming phenotype of ATL cells.
The biological signi¢cance of the induction of ISGs in the
course of cellular transformation is unclear and inconsistent
activation of the IP-10 gene in primary ATL cells rather ar-
gues against this possibility. However, since accumulating evi-
dence demonstrates that several IRFs act di¡erently on ISREs
in a promoter-speci¢c manner, the induction of a discrete set
of ISGs could be involved in the transformed phenotype and
further study of such genes should elucidate a close link be-
tween Rel/NF-UB activity and interferon signaling in cellular
transformation.
Acknowledgements: This work was supported by a Grant-in-Aid for
Scienti¢c Research to J.F. from the Ministry of Education, Science,
Sports, Culture and Technology, Japan.
References
[1] Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna,
J.D. and Gallo, R.C. (1980) Proc. Natl. Acad. Sci. USA 77,
7415^7419.
[2] Yoshida, M., Seiki, M., Yamaguchi, K. and Takatsuki, K. (1984)
Proc. Natl. Acad. Sci. USA 81, 2534^2537.
[3] Akagi, T., Ono, H., Nyunoya, H. and Shimotohno, K. (1997)
Oncogene 14, 2071^2078.
[4] Suzuki, T., Uchida-Toita, M. and Yoshida, M. (1999) Oncogene
18, 4137^4143.
[5] Smith, M.R. and Greene, W.C. (1991) J. Clin. Invest. 88, 1038^
1042.
[6] Yamaoka, S., Inoue, H., Sakurai, M., Sugiyama, T., Hazama,
M., Yamada, T. and Hatanaka, M. (1996) EMBO J. 15, 873^887.
[7] Matsumoto, K., Shibata, H., Fujisawa, J.I., Inoue, H., Hakura,
A., Tsukahara, T. and Fujii, M. (1997) J. Virol. 71, 4445^4451.
[8] Suzuki, T., Kitao, S., Matsushime, H. and Yoshida, M. (1996)
EMBO J. 15, 1607^1614.
[9] Rosin, O., Koch, C., Schmitt, I., Semmes, O.J., Jeang, K.T. and
Grassmann, R. (1998) J. Biol. Chem. 273, 6698^6703.
[10] Sun, S.C. and Ballard, D.W. (1999) Oncogene 18, 6948^6958.
[11] Mori, N., Fujii, M., Ikeda, S., Yamada, Y., Tomonaga, M.,
Ballard, D.W. and Yamamoto, N. (1999) Blood 93, 2360^2368.
[12] Ito, T., Kito, K., Adati, N., Mitsui, Y., Hagiwara, H. and Saka-
ki, Y. (1994) FEBS Lett. 351, 231^236.
[13] Furuta, R.A., Sugiura, K., Kawakita, S., Inada, T., Ikehara, S.,
Matsuda, T. and Fujisawa, J. (2002) J. Virol. 76, 2703^2713.
[14] Hirai, H., Suzuki, T., Fujisawa, J., Inoue, J. and Yoshida, M.
(1994) Proc. Natl. Acad. Sci. USA 91, 3584^3588.
[15] Logeat, F., Israel, N., Ten, R., Blank, V., Le Bail, O., Kourilsky,
P. and Israel, A. (1991) EMBO J. 10, 1827^1832.
[16] Perelygin, A.A., Scherbik, S.V., Zhulin, I.B., Stockman, B.M.,
Li, Y. and Brinton, M.A. (2002) Proc. Natl. Acad. Sci. USA
99, 9322^9327.
[17] Luster, A.D., Unkeless, J.C. and Ravetch, J.V. (1985) Nature
315, 672^676.
[18] Friedman, J., Trahey, M. and Weissman, I. (1993) Proc. Natl.
Acad. Sci. USA 90, 6815^6819.
[19] Schwarz, D.A., Katayama, C.D. and Hedrick, S.M. (1998) Im-
munity 9, 657^668.
[20] Xiao, G.H., Jin, F. and Yeung, R.S. (1995) Oncogene 11, 81^87.
[21] Matena, K., Boehm, T. and Dear, N. (1998) Genomics 48, 117^
120.
[22] Hirai, H., Fujisawa, J., Suzuki, T., Ueda, K., Muramatsu, M.,
Tsuboi, A., Arai, N. and Yoshida, M. (1992) Oncogene 7, 1737^
1742.
[23] Trahey, M. and Weissman, I.L. (1999) Proc. Natl. Acad. Sci.
USA 96, 3006^3011.
[24] Giralt, M., Carrasco, J., Penkowa, M., Morcillo, M.A., Santa-
maria, J., Campbell, I.L. and Hidalgo, J. (2001) Exp. Neurol.
168, 334^346.
[25] Cohen, B., Peretz, D., Vaiman, D., Benech, P. and Chebath, J.
(1988) EMBO J. 7, 1411^1419.
[26] Alexopoulou, L., Holt, A.C., Medzhitov, R. and Flavell, R.A.
(2001) Nature 413, 732^738.
[27] Liu, L., Paul, A., MacKenzie, C.J., Bryant, C., Graham, A. and
Plevin, R. (2001) Br. J. Pharmacol. 134, 1629^1638.
[28] Zhang, L., Wu, L., Hong, K. and Pagano, J.S. (2001) J. Virol.
75, 12393^12401.
[29] Hanon, E., Hall, S., Taylor, G.P., Saito, M., Davis, R., Tanaka,
Y., Usuku, K., Osame, M. and Weber, J.N. (2000) Blood 95,
1386^1392.
[30] Yamagata, T., Nishida, J., Tanaka, S., Sakai, R., Mitani, K.,
Yoshida, M., Taniguchi, T., Yazaki, Y. and Hirai, H. (1996)
Mol. Cell. Biol. 16, 1283^1294.
[31] Sharma, S., Manane, Y., Grandvaux, N., Bartlett, J., Petropou-
los, L., Lin, R. and Hiscott, J. (2000) AIDS Res. Hum. Retro-
viruses 16, 1613^1622.
[32] Hrdlickova, R., Nehyba, J. and Bose Jr., H.R. (2001) Mol. Cell.
Biol. 21, 6369^6386.
[33] Mariner, J.M., Mamane, Y., Hiscott, J., Waldmann, T.A. and
Azimi, N. (2002) J. Immunol. 168, 5667^5674.
FEBS 27073 12-3-03
T. Shimizu et al./FEBS Letters 539 (2003) 73^77 77
